Model Predicts Progression to Overt Primary Myelofibrosis
: A model for predicting overt primary myelofibrosis survival in those with prefibrotic primary myelofibrosis showed good predictive ability and clinical value.
Read More
Rare Blood Disorders
Thrombosis in MPN Impact Disease Course, Comorbidities
Thrombosis events in patients with myeloproliferative neoplasms may signal a more aggressive disease course, including myelofibrosis progression and mortality.
Read More
#VisualAbstract: Deferoxamine, Deferasirox, and Deferiprone Triple Iron Chelator Combination Therapy for β-Thalassaemia
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
Which Factors Predict Thrombotic Events in Essential Thrombocythemia?
The risk for disease progression, thrombosis, and mortality in essential thrombocythemia can be predicted with “readily available” patient information.
Read More
Steatotic Liver Disease Has No Impact on Outcomes in ET, PV
Steatotic liver disease shows no impact on clinical outcomes for patients with essential thrombocythemia and polycythemia.
Read More
Plasma Protein Has Potential to Refine Mastocytosis Diagnoses
Plasma protein profiling can help discern systemic mastocytosis subtypes.
Read More
Assessing and Managing Bleeding Risk Pre-Surgery in Patients With MPNs
Risk assessment and perioperative management are important aspects of improving QOL and preventing complications in surgeries for patients with MPNs.
Read More